Abstract
The present application relates to a process for the preparation of pure (S)-1-(4-fluorophenyl)-1-(2-(piperazin-1-yl)pyrimidin-5-yl)ethan-1-amine of formula-2 or its salt which is a key intermediate used in the preparation of Avapritinib.
Formula-2.
The present invention also provides a process for the preparation of crystalline form-C of Avapritinib.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center; Hyderabad, India; Srinivasan Thirumalai Rajan; Sagyam Rajeshwar Reddy; Revu Satyanarayana, Bakthavachalam Ananthan; Kommera Rajasekhar; Kondeti Raju; Chitikela Rama Teerdha and Cherukula Srikanth, "Process for the preparation of Avapritinib and its intermediates", Technical Disclosure Commons, (November 16, 2026)
https://www.tdcommons.org/dpubs_series/13084